These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11793826)

  • 1. [Administration of glucocorticosteroids to premature infants: increasing evidence of adverse effects].
    van Bel F
    Ned Tijdschr Geneeskd; 2001 Dec; 145(52):2521-5. PubMed ID: 11793826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P
    Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses.
    Yates HL; Newell SJ
    Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F299-303. PubMed ID: 21427126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
    Ambalavanan N; Tyson JE; Kennedy KA; Hansen NI; Vohr BR; Wright LL; Carlo WA;
    Pediatrics; 2005 Mar; 115(3):e249-54. PubMed ID: 15713907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal glucocorticoids and the developing brain: mechanisms of action.
    Matthews SG
    Semin Neonatol; 2001 Aug; 6(4):309-17. PubMed ID: 11972432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in antenatal corticosteroid treatment.
    Klinger G; Koren G
    Can Fam Physician; 2000 Aug; 46():1571-3. PubMed ID: 10955173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?
    Barrington KJ
    CMAJ; 2001 Jul; 165(1):33-4. PubMed ID: 11468952
    [No Abstract]   [Full Text] [Related]  

  • 9. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM; Carbone J; Belden L; Borgida AF; Herson V
    Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
    Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
    Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal cerebral structure is present at term in premature infants.
    Inder TE; Warfield SK; Wang H; Hüppi PS; Volpe JJ
    Pediatrics; 2005 Feb; 115(2):286-94. PubMed ID: 15687434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM; Washburn LK; Nixon PA; Goldstein DJ
    Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of antenatal glucocorticoids according to the cause of very premature birth.
    Foix-L'helias L; Baud O; Lenclen R; Kaminski M; Lacaze-Masmonteil T
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F46-8. PubMed ID: 15613573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal betamethasone: reassuring long-term data.
    Prescrire Int; 2008 Apr; 17(94):73. PubMed ID: 18536142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial or complete antenatal steroids treatment and neonatal outcome in extremely low birth weight infants < or =1000 g: is there a dose-dependent effect?
    Salhab WA; Hynan LS; Perlman JM
    J Perinatol; 2003 Dec; 23(8):668-72. PubMed ID: 14647166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of adverse neurological development for late preterm infants.
    Petrini JR; Dias T; McCormick MC; Massolo ML; Green NS; Escobar GJ
    J Pediatr; 2009 Feb; 154(2):169-76. PubMed ID: 19081113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS; Eichorst D; Lala-Black B; Gonzalez R
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for cerebral palsy in preterm infants.
    Takahashi R; Yamada M; Takahashi T; Ito T; Nakae S; Kobayashi Y; Onuma A
    Early Hum Dev; 2005 Jun; 81(6):545-53. PubMed ID: 15935932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.